Moderna surges 14% on Wolfe upgrade, reclaims $150

MRK -0.29% SBFM -38.57%

1. 1Moderna (MRNA) shares jumped 14% on Tuesday, reclaiming the $150 level
2. 2Wolfe Research upgraded the stock from Underperform to Peer Perform and projected peak revenue of $9.2 billion
3. 3Investors cited the successful late-stage study of its melanoma therapy for lowering intismeran risk and clarifying the approval path with Merck

Source Stocktwits +1 · View original ↗

Today's 5 AI picks, all free

Nothing hidden: past picks and how they did against the S&P 500.

See today's picks →